Concomitant t(8;21) and trisomy 4 in a patient with Acute Myeloid Leukemia (AML)

by Phan CL, Ong TC, Chang KM, Zubaidah Z, Puteri Jamilatul NMB
Published 2010

Apparent factor IX inhibitor.

by Jameela, S, Rozika, P, Rizalman, J, Phan, CL, Visalachy, P, Chang, KM
Published 2011

Experience in Using Hypercvad Combined with Alemtuzumab in Treating Peripheral T-Cell and T/NK-Cell Neoplasms

by Kuan, J.W., Lau, N.S., Chang, K.M., Tan, S.M., Ong, T.C., Purushothamany, V.
Published 2019

Polymorphisms in methylenetetrahydrofolate reductase gene and risk of non-Hodgkin lymphoma in a multi-ethnic population

by Sujatha, S., Gan, G.G., Zain, S.M., Haerian, B.S., Bee, P.C., Lian, L.H., Chang, K.M., Ong, T.C., Mohamed, Z.
Published 2014

Effect of Mouthrinses on Microhardness and Wear of Composite and Compomer Restoratives

by Yap, A.U.J., Tan, B.W.Y., Tay, L.C., Chang, K.M., Loy, T.K., Mok, B.Y.Y.
Published 2014

Medication-related issues associated with adherence to long-term tyrosine kinase inhibitors for controlling chronic myeloid leukemia: a qualitative study

by Tan, B.K., Tan, S.B., Chen, L.C., Chang, K.M., Chua, S.S., Balashanker, S., Kamarul Jaman, H.N.B., Edmund, S.C., Bee, P.C.
Published 2017